发明名称 |
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
摘要 |
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives. |
申请公布号 |
US8822511(B2) |
申请公布日期 |
2014.09.02 |
申请号 |
US201314033117 |
申请日期 |
2013.09.20 |
申请人 |
Incyte Corporation |
发明人 |
Combs Andrew P.;Yue Eddy W.;Sparks Richard B.;Zhu Wenyu |
分类号 |
A61K31/4245;C07D413/12;C07D271/08 |
主分类号 |
A61K31/4245 |
代理机构 |
Fish & Richardson P.C. |
代理人 |
Fish & Richardson P.C. |
主权项 |
1. A method of treating melanoma in a patient, comprising administering to said patient a therapeutically effective amount of a compound selected from compounds of Formula I and compounds of Formula F28:or a pharmaceutically acceptable salt thereof, and an antibody selected from an anti-CTLA-4 antibody and an anti-PD-1 antibody; wherein said treating refers to inhibiting melanoma or ameliorating melanoma;
wherein: R1 is NH2 or CH3; R2 is Cl, Br, CF3, CH3, or CN; R3 is H or F; R4 is F, Cl, Br, or I; and n is 1 or 2. |
地址 |
Wilmington DE US |